WO2008143255A1 - 細胞集団の製造方法 - Google Patents
細胞集団の製造方法 Download PDFInfo
- Publication number
- WO2008143255A1 WO2008143255A1 PCT/JP2008/059238 JP2008059238W WO2008143255A1 WO 2008143255 A1 WO2008143255 A1 WO 2008143255A1 JP 2008059238 W JP2008059238 W JP 2008059238W WO 2008143255 A1 WO2008143255 A1 WO 2008143255A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cell population
- cell
- fibronectin
- production
- fragment
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 210000004027 cell Anatomy 0.000 abstract 6
- 102000016359 Fibronectins Human genes 0.000 abstract 3
- 108010067306 Fibronectins Proteins 0.000 abstract 3
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 3
- 239000012634 fragment Substances 0.000 abstract 2
- 238000002659 cell therapy Methods 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/24—Mucus; Mucous glands; Bursa; Synovial fluid; Arthral fluid; Excreta; Spinal fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/515—CD3, T-cell receptor complex
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/52—Fibronectin; Laminin
Abstract
工程(1):T細胞を含有する細胞集団からCD8陽性T細胞を除去、もしくはCD4陽性T細胞を採取することにより培養に供する細胞集団を調製する工程、及び工程(2):前記工程(1)で得られた細胞集団を、下記(A)及び(B)の存在下で培養する工程〔(A)フィブロネクチン、フィブロネクチンのフラグメント及びフィブロネクチンのフラグメントの混合物からなる群より選択される少なくとも1つ(B)CD3リガンド〕を包含することを特徴とする細胞集団の製造方法。当該製造方法により得られる細胞集団は、細胞医療による疾患の治療に極めて有用である。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009515246A JPWO2008143255A1 (ja) | 2007-05-22 | 2008-05-20 | 細胞集団の製造方法 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007135266 | 2007-05-22 | ||
JP2007-135266 | 2007-05-22 | ||
JP2007-272535 | 2007-10-19 | ||
JP2007272535 | 2007-10-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008143255A1 true WO2008143255A1 (ja) | 2008-11-27 |
Family
ID=40031951
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/059238 WO2008143255A1 (ja) | 2007-05-22 | 2008-05-20 | 細胞集団の製造方法 |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPWO2008143255A1 (ja) |
TW (1) | TW200914613A (ja) |
WO (1) | WO2008143255A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130142766A1 (en) * | 2010-08-10 | 2013-06-06 | Katsuyuki Dodo | Production method for cell populations |
JP2018038409A (ja) * | 2010-02-03 | 2018-03-15 | 国立大学法人 東京大学 | 多能性幹細胞を用いた免疫機能再建法 |
US10787642B2 (en) | 2010-02-03 | 2020-09-29 | The University Of Tokyo | Method for reconstructing immune function using pluripotent stem cells |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005179299A (ja) * | 2003-12-22 | 2005-07-07 | Hokkaido Technology Licence Office Co Ltd | 改変標的化t細胞の製造方法及び医薬 |
WO2007040105A1 (ja) * | 2005-09-30 | 2007-04-12 | Takara Bio Inc. | T細胞集団の製造方法 |
-
2008
- 2008-05-20 JP JP2009515246A patent/JPWO2008143255A1/ja active Pending
- 2008-05-20 WO PCT/JP2008/059238 patent/WO2008143255A1/ja active Application Filing
- 2008-05-22 TW TW097118944A patent/TW200914613A/zh unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005179299A (ja) * | 2003-12-22 | 2005-07-07 | Hokkaido Technology Licence Office Co Ltd | 改変標的化t細胞の製造方法及び医薬 |
WO2007040105A1 (ja) * | 2005-09-30 | 2007-04-12 | Takara Bio Inc. | T細胞集団の製造方法 |
Non-Patent Citations (6)
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2018038409A (ja) * | 2010-02-03 | 2018-03-15 | 国立大学法人 東京大学 | 多能性幹細胞を用いた免疫機能再建法 |
US10787642B2 (en) | 2010-02-03 | 2020-09-29 | The University Of Tokyo | Method for reconstructing immune function using pluripotent stem cells |
US20130142766A1 (en) * | 2010-08-10 | 2013-06-06 | Katsuyuki Dodo | Production method for cell populations |
US9670459B2 (en) | 2010-08-10 | 2017-06-06 | Takara Bio Inc. | Production method for cell populations |
Also Published As
Publication number | Publication date |
---|---|
TW200914613A (en) | 2009-04-01 |
JPWO2008143255A1 (ja) | 2010-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007002136A3 (en) | Differentiation of primate pluripotent stem cells to cardiomyocyte-lineage cells | |
WO2006136953A3 (en) | Method of producing organotypic cell cultures | |
GB2428044A (en) | Method of forming mesenchymal stem cells from embryonic stem cells | |
WO2008054825A8 (en) | Mixed cell populations for tissue repair and separation technique for cell processing | |
IL181588A (en) | METHODS OF PRODUCING TNFR-Ig IN A LARGE-SCALE PRODUCTION CELL CULTURE | |
WO2013102084A3 (en) | Fermentative production of alcohols | |
WO2008024769A3 (en) | Intensified perfusion production method | |
WO2008006038A3 (en) | Methods and compositions for butanol production | |
WO2008090770A1 (ja) | L-アミノ酸を生産する微生物及びl-アミノ酸の製造法 | |
MX2009009970A (es) | Generacion de bloques de construccion quimicos a partir de biomasa vegetal mediante la despolimerizacion selectiva. | |
PL2274419T3 (pl) | Sposoby wytwarzania mikromieszków włosowych i brodawek de novo i stosowanie ich w badaniach in vitro i przeszczepach in vivo | |
BR112012009828A8 (pt) | método para a produção de uma imunoglobulina glicosilada | |
AR048559A1 (es) | Negro de carbono y proceso de etapas multiples para prepararlo | |
SG10201803982TA (en) | Antibodies and processes for preparing the same | |
WO2007143117A3 (en) | Differentiation of primate pluripotent cells to hepatocyte-lineage cells | |
ATE524483T1 (de) | Verfahren zur herstellung eines glykosids eines mono- oder diacylglyzerinprodukts aus einem pflanzlichen material | |
MY184072A (en) | Increasing virus like particle yield in plants | |
WO2008143255A1 (ja) | 細胞集団の製造方法 | |
WO2009071428A3 (de) | Verfahren zur erzeugung von biogas unter verwendung eines gärsubstrats mit eingestellter ammoniumstickstoffkonzentration | |
WO2008111430A1 (ja) | γδT細胞集団の製造方法 | |
WO2006119860A8 (de) | Zellkultursystem sowie verfahren zur kultivierung einer zellkultur | |
WO2009106835A3 (en) | Production process | |
WO2013012269A3 (ko) | 전능성 줄기세포로부터 희소돌기아교 전구세포의 제조 방법 | |
WO2010028632A3 (de) | Verfahren zur herstellung von bakteriell synthetisierter cellulose und cellulosehaltigem material in flächiger form | |
WO2008111506A1 (ja) | 遺伝子導入細胞調製方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08764397 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2009515246 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08764397 Country of ref document: EP Kind code of ref document: A1 |